NCT06726512Not yet recruiting
Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy
Source: ClinicalTrials.gov · Last updated 10 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The primary endpoint is the assessment of the clinical value of a novel high-resolution mobile PET-CT scanner for intraoperative margin assessment in oral squamous cell carcinoma, soft tissue sarcoma and osteosarcoma surgery. The predicted margin status will be correlated with the margin status determined with histopathology.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 16 Oct 2024
- Start date
- Jan 2025
- Primary completion date
- Oct 2025
- Lead sponsor
- University Medical Center Groningen
- Diseases
- Head and neck cancer, Sarcoma
- NCT number
- NCT06726512
What you commit to
- Study type: Interventional
- Planned participants: 30
- From Jan 2025 to the primary completion date, Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient has previously received radiotherapy of the primary tumor region;
- Patient has participated in other clinical studies with radiation exposure of more than 1 mSv in the past 12 months;
Other illness
- Medical or psychiatric conditions that compromise the patient's ability to give informed consent;
Lab values
- A blood glucose level over 200 mg/dL on the day of surgery.
Other
- Pregnancy or lactation.
Who the study is looking for
- Age ≥18 years.
- Patient is confirmed with oral squamous cell carcinoma, soft tissue sarcoma or osteosarcoma.
- Patient is indicated to undergo curative surgery of the primary tumor.
- Patient is estimated compliant for study participation by the investigator.
- Written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Medical Center Groningen Coordinator of this site? Confirm its status | Groningen | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.